Is Enliven Therapeutics, Inc. technically bullish or bearish?

Nov 05 2025 11:24 AM IST
share
Share Via
As of October 31, 2025, Enliven Therapeutics, Inc. shows a bullish technical trend with positive momentum from MACD and moving averages, but caution is advised due to mixed signals from KST and Bollinger Bands, alongside underperformance compared to the S&P 500.
As of 31 October 2025, the technical trend for Enliven Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The daily moving averages are mildly bullish, supporting the overall bullish stance. However, the weekly KST and Bollinger Bands present some bearish signals, and the RSI shows no signal on both weekly and monthly time frames.

In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -15.51% compared to the S&P 500's 16.30%, and a one-year return of -31.20% versus the S&P 500's 19.89%. Overall, the current technical stance is bullish but with caution due to mixed signals from some indicators.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News